Jade Biosciences, Inc. (JBIO) short interest & options flow
NASDAQJade Biosciences enters October with bears in control of the price action but the options market telling a sharply different story, a split that makes positioning here unusually hard to read. Short interest has become the defining feature of this name. Bears have built a position representing nearly 24% of the free float, up 8% over the past week and up 29% over the past month…
JBIO short interest surges 58% in one week to 12.8% of float, driven by biotech volatility and pre-Phase 3 uncertainty.
- Market cap
- $992M
- Next earnings
- 17 Nov 2026
Key data as of 10 Nov 2026
Latest signals on JBIO
- Short Interest
JBIO short interest surges 58% in one week to 12.8% of float, driven by biotech volatility and pre-Phase 3 uncertainty.
- Utilization
JBIO utilization hits 100%, matching its 52-week peak, as short interest surges 33% in one day to 9.2% of float.
JBIO news and analysis
RSSNo long-form analysis yet for JBIO. Pulse alerts and the live data picture are available on ORTEX.
Open JBIO on ORTEX →Want the live picture for JBIO?
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for JBIO — free to start on ORTEX.
Sign up for free →Open JBIO on ORTEX